Registration Dossier

Ecotoxicological information

Toxicity to aquatic algae and cyanobacteria

Currently viewing:

Administrative data

Link to relevant study record(s)

Description of key information

Experimental data were reviewed by U. Hommen at the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME). The report is a weight of evidence approach to an extensive body of literature on acute toxicity of aquatic organisms to cyanides, including 43 species (28 freshwater and 15 marine species) from eight major taxonomic groups; and an extensive body of literature on chronic toxicity of aquatic organisms to cyanides, including 13 species (eight freshwater and five marine species) from five major taxonomic groups. The report uses a methodology for species sensitivity distribution consistent with EU guidance (Technical Guidance Document for Deriving Environmental Quality Standards), from which an acute HC5 and a chronic HC5 were derived. 

Key value for chemical safety assessment

EC50 for freshwater algae:
15.8 µg/L
EC50 for marine water algae:
15.8 µg/L
EC10 or NOEC for freshwater algae:
2 µg/L
EC10 or NOEC for marine water algae:
2 µg/L

Additional information

The acute HC5 value of 15.8 ug/L value served as the point of departure for the derivation of the PNECaquatic for intermittent releases for both freshwater and saltwater species.  The species sensitivity distribution (SSD) for acute aquatic toxicity developed by Hommen (2011) is similar to the SSD derived by the ECETOC Joint Assessment of Commodity Chemicals (2007).  The SSD by Hommen includes more recent guideline studies on acute aquatic toxicity.  The HC5 reported by Hommen for all aquatic species (15.8 ug/L) is lower than the EC50 values for the most sensitive freshwater and marine algal taxa (45 ug/L and 57 ug/L, respectively) as identified by ECETOC (2007).

The chronic HC5 value of 2.0 ug/L value served as the point of departure for the derivation of the chronic PNECaquatic for both freshwater and saltwater species. The species sensitivity distribution (SSD) for acute aquatic toxicity developed by Hommen (2011) is similar to the SSD derived by the ECETOC Joint Assessment of Commodity Chemicals (2007).  The SSD by Hommen includes more recent guideline studies on chronic aquatic toxicity.  The chronic HC5 reported by Hommen for all aquatic species (2.0 ug/L) is higher than the chronic toxicity HC5 of 1.1 ug/L for all aquatic species as estimated by ECETOC (2007).

Potassium cyanide and sodium cyanide can be considered as a chemical category, along with hydrogen cyanide (HCN) and acetone cyanohydrin (ACH, also known as 2-hydroxy-2-methylpropanenitrile), based on structural similarity, similar physico-chemical properties and common breakdown/metabolic products in physical and biological systems. Particular attention is paid to the dissociation constant of HCN. In the vast majority of environmental and physiologic conditions, the cyanide salts will dissolve in water to form hydrogen cyanide. The physico-chemical hazards and toxicity result from the activity of this common proximal toxicant, HCN. Support for this category approach is provided in examination of acute and chronic toxicity by oral, dermal, ocular and intraperitoneal administration of various forms of cyanide and in aquatic and terrestrial compartments of the environment, which provide consistent and comparable values when expressed as mmol/kg bw.  An ECETOC Task Force, in the 2007 ECETOC Joint Assessment of Commodity Chemicals ( JACC ) Report No. 53, “Cyanides of Hydrogen, Sodium and Potassium, and Acetone Cyanohydrin (CAS No. 74-90-8, 143-33-9, 151-50-8 and 75-86-5)” supports the development of this chemical category. Hydrogen cyanide (Index No.006-006-00-X) and salts of hydrogen cyanide (Index No.006-007-00-5) are both listed in Annex VI,Table 3.1 of Regulation (EC) No. 1272/2008, entry 006-007-00-5, and are restricted in comparable ways taking into account physical characteristics. Thus, the assignment of potassium cyanide and sodium cyanide to a chemical category does not result in a less protective regulatory status.